What is the current state of research on long-term therapy using PARP inhibitors in patients with BRCA mutations?
Hassan GHAZAL
oncologist, Dubai
oncologist, Dubai
As the BCU 2024 co-president, what's your goal for next edition of the congress end of January 2025?
Willy Vangu
nuclear medicine, Johannesburg, South Africa
Could you present the AROMA association and explain what will be the topic addressed at the BCU Congress?
Yazid BELKACEMI
Chairman of the Radiation Oncology Department and the Henri-Mondor Breast Center, Henri- Mondor University Hospital, Créteil, France
At what stage do you integrate liquid biopsy into breast cancer management? How early?
Simon NAYLER
pathologist, Johanesburgh, South Africa
Genetic assessment and management in high-risk patients.
Pascal PUJOL
Genetician, Montpellier, France